Myhep LVIR Tablet (Ledipasvir/Sofosbuvir)

Myhep Lvir Tablet is a medicine that contains the active substances ledipasvir and sofosbuvir. It is indicated to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C is a virus that mainly infects the liver. It is mainly triggered by a virus named Flavivirus. Most patients remain asymptomatic, and the symptoms show up only when they develop chronic liver disease or cirrhosis. The progression of liver disease is faster in people who consume alcohol and those with a weak immune system. The main treatment goal for Hepatitis C infection is complete eradication of the virus causing this infection

Treatment of hepatitis C virus (HCV) infection

The active substances in the Myhep Lvir Tablet work together by blocking two different proteins that the virus needs to grow and reproduce itself, allowing the infection to be permanently eliminated from the body

Inform your doctor about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications, including rifampicin, rifabutin, St. John's wort, carbamazepine, phenobarbital, phenytoin, and rosuvastatin, may interact with Myhep Lvir Tablet reducing effectiveness by causing undesirable side effects

• Store the Myhep Lvir Tablet at a controlled room temperature of (30°C).
• Keep it out of reach of children

It is an orally available prescription drug. Your doctor will decide the dose and duration of Myhep Lvir Tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet with or without food. Do not break, chew, or crush the tablet. Swallow the whole tablet with water